All News

Pharmacists can provide guidance to administrators, teachers on insulin storage, dosage times.

From newsworthy moments to groundbreaking research, these are the most popular articles in the intravenous immunoglobulin space, published on Pharmacy Times® during 2022.

Targeted therapies have greatly improved patient outcomes over the past 20 years.

Pharmacists and student pharmacists became the center of responding to the Monkeypox outbreak by providing immunizations to their communities.

American Institute of the History of Pharmacy posts the collection of pharmacist Daniel Shifrin on its website.

Investigators hope findings of study in mice help improve treatment for individuals with acute kidney injury.

By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.

When used as directed, non pharmaceutical products provide swift relief, but patients with persistent or severe pain should see a physician.

Pharmacists have been increasingly recognized as key partners in the clinical services needed to manage the pandemic.

All primary and ranked secondary endpoints of the study were met at week 16, which were sustained or improved through week 24 and were coupled with patient-reported improvements compared with placebo in treating psoriatic arthritis.

Financial assistance platforms improve patient outcomes and the pharmacy bottom line.

Associated postherpetic neuralgia risk factors are history of diabetes mellitus, age, and immune-related disease.

The amplitude of vocal cord movement may indicate patient health and wellbeing.

Lack of access to novel therapies, especially within the cancer space, initiated the road to patient navigation.

The additional indication expands its therapeutic role beyond advanced non-small cell lung cancer.

Age was a contributing factor of chronic kidney disease and albuminuria in patients with type 1 and type 2 diabetes.

Similar symptoms often make it difficult for patients to tell the contagious respiratory conditions apart.

Cariprazine (Vraylar; AbbVie, Gedeon Richter) is indicated as an adjunctive therapy to antidepressants for treating adult patients with major depressive disorder.

Although physical activity and the practice of being present in the moment are associated with many benefits, analysis shows that neither led to measurable improvements in brain health.

Investigators establish that audio and/or facial video features have been most analyzed by machine learning, followed by electroencephalography signals.

Specific immune checkpoint inhibitors added to frontline chemotherapy have transformed modern clinical practice.

Identifying how survivors adjust to their cancer may help health care providers provide tailored self-management skills.

The median progression-free survival and overall survival were 7.4 and 14.7 months, respectively, in chemotherapy-naïve patients with advanced or recurrent biliary tract cancer.

Treatment observably eased obsessive-compulsive disorder symptom severity in young patients, however, symptoms still caused students to be absent from school at least 2 days every month.

Traditionally, endemic fungi are characterized by geographical distribution, however, disease-causing fungi may infect people beyond these havens.

Clinical oncology pharmacist Amy Indorf, PharmD, BCOP, discusses her presentation on the role of PARP inhibitors for ovarian cancer.

Merck and Moderna’s adjuvant melanoma treatment shows reduced risk of recurrence or death by 44% compared with pembrolizumab alone.

A randomized study of renin-angiotensin system inhibitors in advanced chronic kidney disease found that patients who continued receiving therapy had similar outcomes to those who discontinued treatment.